Cancer Channel
Related Channels


Were you looking for information about Ipilimumab? Ipilumumab is a common misspelling of ipilimumab.
By boosting the immune system and increasing the number of cancer-fighting cells, ipilimumab (Yervoy™) can help slow down the progression of melanoma skin cancer. Specifically, ipilimumab is approved for use when the cancer has spread to other areas in the body or cannot be treated surgically. It is administered intravenously (by IV) by a healthcare provider every three weeks for up to four doses.
Although many people may not have any problems with this medicine, some people who receive ipilimumab will experience side effects, such as fatigue, diarrhea, and a rash.
(For more information, click Ipilimumab. This full-length article offers a complete overview of this medication, including how it works, safety warnings and precautions, and general dosing guidelines. You can also click any of the links in the box to the right for specific information.)
The Zen of Cancer Caregiving - Recharge Your Batteries!
Referring Pages:
Terms of Use
Advertise with Us
Contact Us
About eMedTV
Privacy Policy
Copyright © 2006-2020 Clinaero, Inc.
eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind. Site users seeking medical advice about their specific situation should consult with their own physician. Click Terms of Use for more information.